Urologic aspects of HIV infection

Medical Clinics of North America

Volumn 95, Issue 1, 2011, Pages 129-151

  Shindel, Alan W ^a,b   Akhavan, Ardavan ^c   Sharlip, Ira D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Erectile dysfunction; Genitourinary infection; Genitourinary tumors; Human immunodeficiency virus; Male circumcision

Indexed keywords

ACICLOVIR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMPRENAVIR; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; ATAZANAVIR; AZITHROMYCIN; BOTULINUM TOXIN; CEFIXIME; CEFTRIAXONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIPROFLOXACIN; DOXYCYCLINE; FOSCARNET; IMIQUIMOD; INDINAVIR; LOPINAVIR; NELFINAVIR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; OFLOXACIN; PENICILLIN G; PHOSPHODIESTERASE V INHIBITOR; PODOPHYLLOTOXIN; PROTEINASE INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STEROID 5ALPHA REDUCTASE INHIBITOR; TRICHLOROACETIC ACID; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC THERAPY; BLADDER DISEASE; CD4 LYMPHOCYTE COUNT; CIRCUMCISION; CLINICAL PRACTICE; CONDYLOMA ACUMINATUM; CYSTOSCOPY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; EPIDIDYMITIS; ERECTILE DYSFUNCTION; FERTILITY; GENITAL ULCER; GERM CELL TUMOR; GONORRHEA; HEMATURIA; HERPES SIMPLEX; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INFECTION RISK; KAPOSI SARCOMA; KIDNEY FAILURE; KIDNEY INFECTION; LOWER URINARY TRACT SYMPTOM; MALE; MICTURITION DISORDER; MOLLUSCUM CONTAGIOSUM; MORBIDITY; MYCOBACTERIOSIS; NEPHROLITHIASIS; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; ORCHIECTOMY; PATIENT EDUCATION; PENIS CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATITIS; REVIEW; SAFE SEX; SEXUAL FUNCTION; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; SKIN INFECTION; SKIN ULCER; STONE FORMATION; SYPHILIS; TESTIS TUMOR; ULCUS MOLLE; URETHRITIS; URINARY TRACT FISTULA; URINARY TRACT INFECTION; URINE CULTURE; UROGENITAL TRACT INFECTION; UROGENITAL TRACT TUMOR; UROLITHIASIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CIRCUMCISION, MALE; FEMALE; FEMALE UROGENITAL DISEASES; HIV INFECTIONS; HUMANS; MALE; MALE UROGENITAL DISEASES; PRIMARY HEALTH CARE; URINARY TRACT INFECTIONS;

EID: 78649348226     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.08.017     Document Type: Review

References (125)

1. UNAIDS AIDS epidemic update: 2009 2009, Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO), Geneva (Switzerland).
2. Lee L.K., Dinneen M.D., Ahmad S. The urologist and the patient infected with human immunodeficiency virus or with acquired immunodeficiency syndrome. BJU Int 2001, 88(6):500-510.
3. Lebovitch S., Mydlo J.H. HIV-AIDS: urologic considerations. Urol Clin North Am 2008, 35(1):59-68. vi.
4. Hoepelman A.I., van Buren M., van den Broek J., et al. Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count). AIDS 1992, 6(2):179-184.
5. Heyns C.F., Fisher M. The urological management of the patient with acquired immunodeficiency syndrome. BJU Int 2005, 95(5):709-716.
6. Kwan D.J., Lowe F.C. Genitourinary manifestations of the acquired immunodeficiency syndrome. Urology 1995, 45(1):13-27.
7. Kwan D.J., Lowe F.C. Acquired immunodeficiency syndrome. A venereal disease. Urol Clin North Am 1992, 19(1):13-24.
8. Gokalp A., Gultekin E.Y., Ozdamar S. Genito-urinary tuberculosis: a review of 83 cases. Br J Clin Pract 1990, 44(12):599-600.
9. Brandeis J.M., Baskin L.S., Kogan B.A., et al. Recurrent Staphylococcus aureus renal abscess in a child positive for the human immunodeficiency virus. Urology 1995, 46(2):246-248.
10. Marques L.P., Rioja L.S., Oliveira C.A., et al. AIDS-associated renal tuberculosis. Nephron 1996, 74(4):701-704.
11. van der Reijden H.J., Schipper M.E., Danner S.A., et al. Glomerular lesions and opportunistic infections of the kidney in AIDS: an autopsy study of 47 cases. Adv Exp Med Biol 1989, 252:181-188.
12. Figueiredo A.A., Lucon A.M., Ikejiri D.S., et al. Urogenital tuberculosis in a patient with AIDS: an unusual presentation. Nat Clin Pract Urol 2008, 5(8):455-460.
13. Dinnes J., Deeks J., Kunst H., et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 2007, 11(3):1-196.
14. Moussa O.M., Eraky I., El-Far M.A., et al. Rapid diagnosis of genitourinary tuberculosis by polymerase chain reaction and non-radioactive DNA hybridization. J Urol 2000, 164(2):584-588.
15. Havlir D.V., Barnes P.F. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999, 340(5):367-373.
16. Butler M.R., O'Flynn J.D. Reactivation of genito-urinary tuberculosis: a retrospective review of 838 cases. Eur Urol 1975, 1(1):14-17.
17. Henn L., Nagel F., Dal Pizzol F. Comparison between human immunodeficiency virus positive and negative patients with tuberculosis in Southern Brazil. Mem Inst Oswaldo Cruz 1999, 94(3):377-381.
18. Control CfD Reported HIV status of tuberculosis patients-United States, 1993-2005. MMWR Morb Mortal Wkly Rep 2007, 56(42):1103-1106.
19. Leport C., Rousseau F., Perronne C., et al. Bacterial prostatitis in patients infected with the human immunodeficiency virus. J Urol 1989, 141(2):334-336.
20. Nickel J.C., Shoskes D., Wang Y., et al. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome?. J Urol 2006, 176(1):119-124.
21. Trauzzi S.J., Kay C.J., Kaufman D.G., et al. Management of prostatic abscess in patients with human immunodeficiency syndrome. Urology 1994, 43(5):629-633.
22. Hyun G., Lowe F.C. AIDS and the urologist. Urol Clin North Am 2003, 30(1):101-109.
23. Coburn M. Urological manifestations of HIV infection. AIDS Res Hum Retroviruses 1998, 14(Suppl 1):S23-S25.
24. Dalton A.D., Harcourt-Webster J.N. The histopathology of the testis and epididymis in AIDS-a post-mortem study. J Pathol 1991, 163(1):47-52.
25. De Paepe M.E., Waxman M. Testicular atrophy in AIDS: a study of 57 autopsy cases. Hum Pathol 1989, 20(3):210-214.
26. Kaplan M.H., Sadick N., McNutt N.S., et al. Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol 1987, 16(3 Pt 1):485-506.
27. Cockerell C.J. Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: clinical and histologic aspects. J Am Acad Dermatol 1990, 22(6 Pt 2):1260-1269.
28. Coopman S.A., Johnson R.A., Platt R., et al. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993, 328(23):1670-1674.
29. Workowski K.A., Berman S.M. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006, 55(RR-11):1-94.
30. Belda W., Di Chiacchio N.G., Di Chiacchio N., et al. A comparative study of single-dose treatment of chancroid using thiamphenicol versus Azithromycin. Braz J Infect Dis 2009, 13(3):218-220.
31. Tyring S.K. Molluscum contagiosum: the importance of early diagnosis and treatment. Am J Obstet Gynecol 2003, 189(Suppl 3):S12-S16.
32. Cespedes R.D., Peretsman S.J., Blatt S.P. The significance of hematuria in patients infected with the human immunodeficiency virus. J Urol 1995, 154(4):1455-1456.
33. Zeman A., Donaghy M. Acute infection with human immunodeficiency virus presenting with neurogenic urinary retention. Genitourin Med 1991, 67(4):345-347.
34. Gyrtrup H.J., Kristiansen V.B., Zachariae C.O., et al. Voiding problems in patients with HIV infection and AIDS. Scand J Urol Nephrol 1995, 29(3):295-298.
35. Khan Z., Singh V.K., Yang W.C. Neurogenic bladder in acquired immune deficiency syndrome (AIDS). Urology 1992, 40(3):289-291.
36. Levy R.M., Bredesen D.E., Rosenblum M.L. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 1985, 62(4):475-495.
37. Hermieu J.F., Delmas V., Boccon-Gibod L. Micturition disturbances and human immunodeficiency virus infection. J Urol 1996, 156(1):157-159.
38. Snider W.D., Simpson D.M., Nielsen S., et al. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 1983, 14(4):403-418.
39. Collier A.C., Meyers J.D., Corey L., et al. Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity. Am J Med 1987, 82(3):593-601.
40. Kane C.J., Bolton D.M., Connolly J.A., et al. Voiding dysfunction in human immunodeficiency virus infections. J Urol 1996, 155(2):523-526.
41. McGuire B.B., O'Brien M.F., McLoughlin S., et al. Should patients with symptomatic BPH have a trial of medical therapy by their general practitioner prior to referral for urological assessment?. Ir Med J 2007, 100(4):428-429.
42. Madersbacher S., Marszalek M., Lackner J., et al. The long-term outcome of medical therapy for BPH. Eur Urol 2007, 51(6):1522-1533.
43. Chapple C. Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia. Curr Opin Urol 2010, 20(1):43-48.
44. Seney F.D., Burns D.K., Silva F.G. Acquired immunodeficiency syndrome and the kidney. Am J Kidney Dis 1990, 16(1):1-13.
45. Nadler R.B., Rubenstein J.N., Eggener S.E., et al. The etiology of urolithiasis in HIV infected patients. J Urol 2003, 169(2):475-477.
46. Christin S., Baumelou A., Bahri S., et al. Acute renal failure due to sulfadiazine in patients with AIDS. Nephron 1990, 55(2):233-234.
47. Sawyer M.H., Webb D.E., Balow J.E., et al. Acyclovir-induced renal failure. Clinical course and histology. Am J Med 1988, 84(6):1067-1071.
48. Collin F., Chene G., Retout S., et al. Indinavir trough concentration as a determinant of early nephrolithiasis in HIV-1-infected adults. Ther Drug Monit 2007, 29(2):164-170.
49. Kopp J.B., Miller K.D., Mican J.A., et al. Crystalluria and urinary tract abnormalities associated with indinavir. Ann Intern Med 1997, 127(2):119-125.
50. Itani S., Bartlett J.A. Strategies of antiretroviral therapy in adults. Urol Clin North Am 1999, 26(4):809-820. ix-x.
51. Masarani M., Dinneen M., Coyne K.M., et al. The genitourinary complications of HIV infection in men. Br J Hosp Med (Lond) 2008, 69(3):141-146.
52. Feicke A., Rentsch K.M., Oertle D., et al. Same patient, new stone composition: amprenavir urinary stone. Antivir Ther 2008, 13(5):733-734.
53. Al-Ansari A., Al-Naimi A., Alobaidy A., et al. Efficacy of tamsulosin in the management of lower ureteral stones: a randomized double-blind placebo-controlled study of 100 patients. Urology 2010, 75(1):4-7.
54. Worcester E.M., Coe F.L. Nephrolithiasis. Prim Care 2008, 35(2):369-391. vii.
55. Taylor E.N., Curhan G.C. Diet and fluid prescription in stone disease. Kidney Int 2006, 70(5):835-839.
56. Collazos J., Martinez E., Mayo J., et al. Sexual dysfunction in HIV-infected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002, 31(3):322-326.
57. Karlovsky M., Lebed B., Mydlo J.H. Increasing incidence and importance of HIV/AIDS and gonorrhea among men aged >/= 50 years in the US in the era of erectile dysfunction therapy. Scand J Urol Nephrol 2004, 38(3):247-252.
58. Crum-Cianflone N.F., Bavaro M., Hale B., et al. Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS 2007, 21(1):9-19.
59. Mao L., Newman C.E., Kidd M.R., et al. Self-reported sexual difficulties and their association with depression and other factors among gay men attending high HIV-caseload general practices in Australia. J Sex Med 2009, 6(5):1378-1385.
60. Bancroft J., Carnes L., Janssen E. Unprotected anal intercourse in HIV-positive and HIV-negative gay men: the relevance of sexual arousability, mood, sensation seeking, and erectile problems. Arch Sex Behav 2005, 34(3):299-305.
61. Keegan A., Lambert S., Petrak J. Sex and relationships for HIV-positive women since HAART: a qualitative study. AIDS Patient Care STDS 2005, 19(10):645-654.
62. Wilson T.E., Jean-Louis G., Schwartz R., et al. HIV infection and women's sexual functioning. J Acquir Immune Defic Syndr 2010, 54(4):360-367.
63. Colson A.E., Keller M.J., Sax P.E., et al. Male sexual dysfunction associated with antiretroviral therapy. J Acquir Immune Defic Syndr 2002, 30(1):27-32.
64. Collazos J. Sexual dysfunction in the highly active antiretroviral therapy era. AIDS Rev 2007, 9(4):237-245.
65. Lallemand F., Salhi Y., Linard F., et al. Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors. J Acquir Immune Defic Syndr 2002, 30(2):187-190.
66. Hatzichristou D., Rosen R.C., Derogatis L.R., et al. Recommendations for the clinical evaluation of men and women with sexual dysfunction. J Sex Med 2010, 7(1 Pt 2):337-348.
67. Esposito K., Ciotola M., Giugliano F., et al. Effects of intensive lifestyle changes on erectile dysfunction in men. J Sex Med 2009, 6(1):243-250.
68. Poretsky L., Can S., Zumoff B. Testicular dysfunction in human immunodeficiency virus-infected men. Metabolism 1995, 44(7):946-953.
69. Cohan G.R. HIV-associated hypogonadism. AIDS Read 2006, 16(7):341-345. 348, 352-4.
70. Wunder D.M., Bersinger N.A., Fux C.A., et al. Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antivir Ther 2007, 12(2):261-265.
71. Guaraldi G., Luzi K., Murri R., et al. Sexual dysfunction in HIV-infected men: role of antiretroviral therapy, hypogonadism and lipodystrophy. Antivir Ther 2007, 12(7):1059-1065.
72. Kell P., Sadeghi-Nejad H., Price D. An ethical dilemma: erectile dysfunction in the HIV-positive patient: to treat or not to treat. Int J STD AIDS 2002, 13(6):355-357.
73. Nettles C.D., Benotsch E.G., Uban K.A. Sexual risk behaviors among men who have sex with men using erectile dysfunction medications. AIDS Patient Care STDS 2009, 23(12):1017-1023.
74. Ostrow D.G., Plankey M.W., Cox C., et al. Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr 2009, 51(3):349-355.
75. Prestage G., Jin F., Kippax S., et al. Use of illicit drugs and erectile dysfunction medications and subsequent HIV infection among gay men in Sydney, Australia. J Sex Med 2009, 6(8):2311-2320.
76. Cook R.L., McGinnis K.A., Samet J.H., et al. Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted diseases in HIV-infected and HIV-uninfected men. J Gen Intern Med 2010, 25(2):115-121.
77. Sanders S.A., Milhausen R.R., Crosby R.A., et al. Do phosphodiesterase type 5 inhibitors protect against condom-associated erection loss and condom slippage?. J Sex Med 2009, 6(5):1451-1456.
78. Hijazi L., Nandwani R., Kell P. Medical management of sexual difficulties in HIV-positive individuals. Int J STD AIDS 2002, 13(9):587-592.
79. Basson R., Wierman M.E., van Lankveld J., et al. Summary of the recommendations on sexual dysfunctions in women. J Sex Med 2010, 7(1 Pt 2):314-326.
80. Wallace J.I., Paauw D.S., Spach D.H. HIV infection in older patients: when to suspect the unexpected. Geriatrics 1993, 48(6):61-64. 69-70.
81. Skiest D.J., Keiser P. Human immunodeficiency virus infection in patients older than 50 years. A survey of primary care physicians' beliefs, practices, and knowledge. Arch Fam Med 1997, 6(3):289-294.
82. Frodsham L.C., Boag F., Barton S., et al. Human immunodeficiency virus infection and fertility care in the United Kingdom: demand and supply. Fertil Steril 2006, 85(2):285-289.
83. Lyall E.G., Blott M., de Ruiter A., et al. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med 2001, 2(4):314-334.
84. Krieger J.N., Coombs R.W., Collier A.C., et al. Intermittent shedding of human immunodeficiency virus in semen: implications for sexual transmission. J Urol 1995, 154(3):1035-1040.
85. Honeck P., Weigel M., Kwon S.T., et al. Assisted procreation in cases of hepatitis B, hepatitis C or human immunodeficiency virus infection of the male partner. Hum Reprod 2006, 21(5):1117-1121.
86. Krieger J.N., Coombs R.W., Collier A.C., et al. Fertility parameters in men infected with human immunodeficiency virus. J Infect Dis 1991, 164(3):464-469.
87. Muller C.H., Coombs R.W., Krieger J.N. Effects of clinical stage and immunological status on semen analysis results in human immunodeficiency virus type 1-seropositive men. Andrologia 1998, 30(Suppl 1):15-22.
88. Gray R.H., Wawer M.J., Serwadda D., et al. Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 1998, 351(9096):98-103.
89. Silberstein J., Downs T., Lakin C., et al. HIV and prostate cancer: a systematic review of the literature. Prostate Cancer Prostatic Dis 2009, 12(1):6-12.
90. Baynham S.A., Katner H.P., Cleveland K.B. Increased prevalence of renal cell carcinoma in patients with HIV infection. AIDS Patient Care STDS 1997, 11(3):161-165.
91. Patel P., Hanson D.L., Sullivan P.S., et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008, 148(10):728-736.
92. Stebbing J., Gazzard B., Mandalia S., et al. Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma. J Clin Oncol 2004, 22(11):2177-2183.
93. Behler C.M., Kaplan L.D. Advances in the management of HIV-related non-Hodgkin lymphoma. Curr Opin Oncol 2006, 18(5):437-443.
94. D'Agati V., Appel G.B. Renal pathology of human immunodeficiency virus infection. Semin Nephrol 1998, 18(4):406-421.
95. Sokovich R.S., Bormes T.P., McKiel C.F. Acquired immunodeficiency syndrome presenting as testicular lymphoma. J Urol 1992, 147(4):1110-1111.
96. Wilson W.T., Frenkel E., Vuitch F., et al. Testicular tumors in men with human immunodeficiency virus. J Urol 1992, 147(4):1038-1040.
97. Leibovitch I., Baniel J., Rowland R.G., et al. Malignant testicular neoplasms in immunosuppressed patients. J Urol 1996, 155(6):1938-1942.
98. Krain J., Dieckmann K.P. Treatment of testicular seminoma in patients with HIV infection. Report of two cases. Eur Urol 1994, 26(2):184-186.
99. Powles T., Bower M., Shamash J., et al. Outcome of patients with HIV-related germ cell tumours: a case-control study. Br J Cancer 2004, 90(8):1526-1530.
100. Vianna L.E., Lo Y., Klein R.S. Serum prostate-specific antigen levels in older men with or at risk of HIV infection. HIV Med 2006, 7(7):471-476.
101. Crum N.F., Spencer C.R., Amling C.L. Prostate carcinoma among men with human immunodeficiency virus infection. Cancer 2004, 101(2):294-299.
102. Huang S.P., Huang C.Y., Wu W.J., et al. Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy. Int J Cancer 2006, 119(8):1902-1907.
103. Ng T., Stein N.F., Kaminetsky J., et al. Preliminary results of radiation therapy for prostate cancer in human immunodeficiency virus-positive patients. Urology 2008, 72(5):1135-1138. [discussion: 1138].
104. Greene K.L., Albertsen P.C., Babaian R.J., American Urologic Association Prostate-specific antigen (PSA) best practice statement: 2009 update. J Urol 2009, 182(5):2232-2241.
105. Wammack R., Djavan B., Remzi M., et al. Morbidity of transrectal ultrasound-guided prostate needle biopsy in patients receiving immunosuppression. Urology 2001, 58(6):1004-1007.
106. Rao T.K., Filippone E.J., Nicastri A.D., et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984, 310(11):669-673.
107. Gardenswartz M.H., Lerner C.W., Seligson G.R., et al. Renal disease in patients with AIDS: a clinicopathologic study. Clin Nephrol 1984, 21(4):197-204.
108. Coleburn N.H., Scholes J.V., Lowe F.C. Renal failure in patients with AIDS-related complex. Urology 1991, 37(6):523-527.
109. Shah S.N., He C.J., Klotman P. Update on HIV-associated nephropathy. Curr Opin Nephrol Hypertens 2006, 15(4):450-455.
110. Rao T.K. Acute renal failure syndromes in human immunodeficiency virus infection. Semin Nephrol 1998, 18(4):378-395.
111. Bongaarts J., Reining P., Way P., et al. The relationship between male circumcision and HIV infection in African populations. AIDS 1989, 3(6):373-377.
112. Siegfried N., Muller M., Volmink J., et al. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev 2003, 3. CD003362.
113. Vermund S.H., Qian H.Z. Circumcision and HIV prevention among men who have sex with men: no final word. JAMA 2008, 300(14):1698-1700.
114. Auvert B., Taljaard D., Lagarde E., et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005, 2(11):e298.
115. Gray R.H., Kigozi G., Serwadda D., et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007, 369(9562):657-666.
116. Bailey R.C., Moses S., Parker C.B., et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007, 369(9562):643-656.
117. Siegfried N., Muller M., Deeks J.J., et al. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev 2009, 2. CD003362.
118. Krieger J.N., Mehta S.D., Bailey R.C., et al. Adult male circumcision: effects on sexual function and sexual satisfaction in Kisumu, Kenya. J Sex Med 2008, 5(11):2610-2622.
119. Millett G.A., Flores S.A., Marks G., et al. Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA 2008, 300(14):1674-1684.
120. Gust D.A., Wiegand R.E., Kretsinger K., et al. Circumcision status and HIV infection among MSM: reanalysis of a Phase III HIV vaccine clinical trial. AIDS 2010, 24(8):1135-1143.
121. Wawer M.J., Makumbi F., Kigozi G., et al. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet 2009, 374(9685):229-237.
122. McCoombe S.G., Short R.V. Potential HIV-1 target cells in the human penis. AIDS 2006, 20(11):1491-1495.
123. Dinh M.H., McRaven M.D., Kelley Z., et al. Keratinization of the adult male foreskin and implications for male circumcision. AIDS 2010, 24(6):899-906.
124. Patterson B.K., Landay A., Siegel J.N., et al. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol 2002, 161(3):867-873.
125. Price L.B., Liu C.M., Johnson K.E., et al. The effects of circumcision on the penis microbiome. PLoS One 2010, 5(1):e8422.